top of page
Search
Dowdy Jackson
- May 11
- 7 min
Bispecific ADCs: A potential game changer for the next generation of ADCs
Dowdy Jackson, Ph.D. Jackson Consulting Group May 10th 2024 Abstract Antibody drug conjugates (ADCs) have become one of the most sought...
634 views0 comments
Dowdy Jackson
- Mar 20
- 1 min
Antibody Drug Conjugates: Are ADCs a good investment?
Recently, several high-profile ADC deals have been announced. The most prominent deal is Pfizer's acquisition of Seattle Genetics for a...
59 views0 comments
Dowdy Jackson
- Sep 13, 2020
- 2 min
Why The Majority of Oncology Drugs Fail In The Clinic?
Approximately 80-90% of oncology drugs that enter into clinical development (Phase I) never make it to approval (Phase III). Most...
66 views0 comments
© 2018 by Jackson Consulting Group.
bottom of page